Cargando…

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories

Detalles Bibliográficos
Autor principal:	Dapice, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164615/ http://dx.doi.org/10.1016/j.diabres.2022.109355

Ejemplares similares

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

Measles 2018: a tale of two anniversaries
por: Sansonetti, Philippe J
Publicado: (2018)

IDF21-0214 COVID-19 & Diabetes in Canada: Two Global Pandemics Colliding & An Opportunity For Optimizing Data-Driven Diabetes Care Delivery & Outcomes in British Columbia (BC)
por: Leong, W., et al.
Publicado: (2022)

P04.22. Comparison of patient-centeredness and patient-reported health outcomes in integrative medicine hospitals with conventional hospitals in Germany
por: Scheffer, C, et al.
Publicado: (2012)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic
por: Alromaihi, D., et al.
Publicado: (2022)

IDF21-0439 Type 2 Diabetes Mellitus History in the Prognosis of Hospitalized COVID-19 Patients – A Prospective Observational Study
por: Kochuparambil, J.J., et al.
Publicado: (2022)

IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic
por: Khurana, R., et al.
Publicado: (2022)

The Borrelia afzelii outer membrane protein BAPKO_0422 binds human factor-H and is predicted to form a membrane-spanning β-barrel
por: Dyer, Adam, et al.
Publicado: (2015)

IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic
por: Abi Saad, M., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0445 Telehealth utilization in Diabetes Centre during COVID Pandemic in South-Western Sydney: An evolving model of care
por: Manoharan, M., et al.
Publicado: (2022)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

IDF21-0175 Experiences of delivering virtual education workshops for children with type 1 diabetes during the Covid-19 pandemic
por: Chan, P.L.C., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

IDF21-0373 Online education for parents of children and adolescents with newly diagnosed type 1 diabetes during COVID-19 pandemic
por: Kurganovich, A., et al.
Publicado: (2022)

IDF21-0294 Impact of COVID-19 pandemic lockdown in Spain on metabolic control of patients with type 2 diabetes mellitus
por: Cornadó-Cubells, G., et al.
Publicado: (2022)

IDF21-0390 Diabetes related hospital presentations to South-Western Sydney during COVID Pandemic: A retrospective analysis
por: Namboodiri, D., et al.
Publicado: (2022)

IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic
por: Almutairi, M., et al.
Publicado: (2022)

The Heroes of the I.D.F.
por: Gotweter, Y.
Publicado: (1967)

IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India
por: Verma, R., et al.
Publicado: (2022)

IDF21-0678 Telemedicine Use and Selfmanagement Behaviors of Persons with Type 2 DM in Luzon Philippines during the COVID-19 Pandemic
por: Abaigar Jr., M., et al.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0564 The Use of a Digital Self-Care Platform in The Control of Diabetes in People With Diabetes During the COVID-19 Pandemic
por: Jacobs, M., et al.
Publicado: (2022)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

Celebrating 21 years and introducing the 21st anniversary issue
por: Moosa, Yunus, et al.
Publicado: (2021)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

IDF21-0411 Correlation of Chest CT severity score with blood glucose levels in patients with COVID-19
por: Inamdar, A., et al.
Publicado: (2022)

IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects
por: Baidya, A., et al.
Publicado: (2022)

IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department
por: Dhokar, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7td9rsorcjeuugontrcm4sg1aa